Achieving More With Less: US FDA Offers ‘Road Map’ For AI In Rare Diseases

 
• By Sue Sutter
  
Road map
FDA officials described a "road map" for using AI in rare disease drug development. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from United States